One week after warning that the U.K. is undervaluing life sciences manufacturing investments, trade organization the Association of the British Pharmaceutical Industry (ABPI) has issued another call ...

YouTube’s live broadcast on Friday night of the Kansas City Chiefs and Los Angeles Chargers game is set to be a major test of the platform’s programming ambitions. A YouTube commercial in Times Square ...

The U.K. is losing business opportunities in the life sciences sector because the government undervalues the economic and social benefits of investing in the manufacturing of innovative medicines, ...

MANILA, Philippines – The Marcos administration may need to exempt US tech companies from the 12 percent digital value-added tax (VAT) to avoid the higher tariffs that President Donald Trump has ...

Theo Burman is a Newsweek Live News Reporter based in London, U.K. He writes about U.S. politics and international news, with a focus on infrastructure and technology. He has covered technological and ...

STARBASE, Texas—SpaceX launched the 10th test flight of the company's Starship rocket Tuesday evening, sending the stainless steel spacecraft halfway around the world to an on-target splashdown in the ...

NHS patients will lose access to new cutting-edge treatments because of skyrocketing costs, the pharmaceutical giant Novartis has claimed amid a row over drug pricing deals. The warning comes after ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Wes Streeting has vowed not to let pharmaceutical companies “rip off” British taxpayers after talks with the firms over drug pricing. Discussions between the Health Secretary and the pharmaceuticals ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The Health Secretary called off negotiations with drugmakers on Friday after “weeks ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Wes Streeting has walked away from acrimonious talks with pharmaceutical companies over drug pricing after the ...

Officials launched a review of the voluntary scheme for branded medicines pricing, access and growth earlier this year. Proposals that would have seen spending on medicines in the UK increase by ...